3. SUBMISSION OF PHARMACEUTICAL DEVELOPMENT AND RELATED INFORMATION IN COMMON TECHNICAL DOC

Pharmaceutical development information is submitted in Section P . 2 of the CTD . Other information resulting from pharmaceutical development studies could be accommodated by the CTD format in a number of different ways and some specific suggestions are provided below .However , the applican should clearly indicate where the different information i located .In addition to what is submitted in the application certain aspects ( e . g . , product lifecycle management , continua improvement ) of this guideline are handled under the applicant ’ s pharmaceutical quality system ( see ICH Q10 ) .